FYERS
Home
/
Stocks
/
Profit Loss
/
Supriya Lifescience Profit & Loss

Supriya Lifescience Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020
₹190 Cr₹277 Cr₹206 Cr₹200 Cr₹145 Cr₹184 Cr₹186 Cr₹166 Cr₹161 Cr₹158 Cr₹140 Cr₹140 Cr₹132 Cr₹142 Cr₹105 Cr₹112 Cr₹101 Cr₹181 Cr₹117 Cr₹148 Cr₹77 Cr₹132 Cr₹81 Cr
₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr
₹192 Cr₹280 Cr₹209 Cr₹203 Cr₹148 Cr₹187 Cr₹188 Cr₹169 Cr₹163 Cr₹160 Cr₹143 Cr₹143 Cr₹135 Cr₹144 Cr₹108 Cr₹115 Cr₹104 Cr₹185 Cr₹122 Cr₹151 Cr₹79 Cr₹134 Cr₹85 Cr
₹151 Cr₹187 Cr₹141 Cr₹134 Cr₹100 Cr₹123 Cr₹125 Cr₹106 Cr₹103 Cr₹107 Cr₹103 Cr₹112 Cr₹91 Cr₹90 Cr₹94 Cr₹87 Cr₹73 Cr₹109 Cr₹81 Cr₹57 Cr₹64 Cr₹67 Cr₹60 Cr
₹50 Cr₹101 Cr₹75 Cr₹75 Cr₹54 Cr₹71 Cr₹68 Cr₹67 Cr₹65 Cr₹58 Cr₹45 Cr₹34 Cr₹47 Cr₹57 Cr₹17 Cr₹31 Cr₹34 Cr₹79 Cr₹44 Cr₹97 Cr₹17 Cr₹69 Cr₹30 Cr
₹37 L₹47 L₹49 L₹42 L₹51 L₹42 L₹51 L₹43 L₹34 L₹60 L₹49 L₹46 L₹82 L₹71 L₹1 Cr₹78 L₹58 L₹1 Cr₹1 Cr₹17 Cr₹97 L₹1 Cr₹81 L
₹41 Cr₹92 Cr₹67 Cr₹68 Cr₹47 Cr₹64 Cr₹63 Cr₹62 Cr₹60 Cr₹53 Cr₹40 Cr₹30 Cr₹43 Cr₹53 Cr₹13 Cr₹27 Cr₹30 Cr₹75 Cr₹40 Cr₹78 Cr₹14 Cr₹66 Cr₹25 Cr
₹24 Cr₹74 Cr₹50 Cr₹50 Cr₹35 Cr₹50 Cr₹47 Cr₹46 Cr₹45 Cr₹37 Cr₹30 Cr₹24 Cr₹29 Cr₹38 Cr₹10 Cr₹17 Cr₹25 Cr₹46 Cr₹40 Cr₹58 Cr₹8 Cr₹49 Cr₹16 Cr

Share Price Live Stats

Open (₹)912.00
Volume (₹)2.44 L
High (₹)933.15
Upper Circuit1,093.65
Low (₹)902.80
Lower Circuit729.15
Prev Close911.40
52W High (₹)1,085.00
Price917.45
52W Low (₹)545.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)7334.40 Cr
Div. Yield (%)0.11
PE Ratio36.97
Debt to Equity0.00
Price to Book3.80
Book Value148.81
EPS (TTM)24.65
Face Value2.00
ROE (%)19.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
SUPRIYANSE
LTP
1W Low
1W High
Market cap (₹)
1861-38 (-2.00%)
1840.50
1907.80
4,48,316Cr
9438.5+338.5 (3.72%)
9119.50
9615
2,51,737Cr
4930+73 (1.50%)
4823
5000
1,87,594Cr
1117.8-2.2 (-0.20%)
1108.10
1167.70
1,12,618Cr
1373.3-11.7 (-0.84%)
1363.10
1398.40
1,10,515Cr
1945+105 (5.71%)
1832.70
1955
1,04,456Cr
1668.4+15.3 (0.93%)
1646
1704
97,239Cr
2077.8-32.2 (-1.53%)
2060.30
2135.50
95,660Cr
1143-8 (-0.70%)
1134.90
1163.20
95,421Cr
2238.4-89.5 (-3.84%)
2235.10
2331.60
93,596Cr
917.45+64.6 (7.57%)
864
933.15
7,334Cr

Key Highlights of Supriya Lifescience Ltd’s P&L

In 2025-03-31, Supriya Lifescience Ltd reported total revenue of ₹696.49Cr, compared with ₹570.34Cr in 2024-03-31, reflecting Supriya Lifescience Ltd turnover.

Depreciation was ₹20.44Cr and finance costs were ₹1.83Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹248.48Cr in 2025-03-31 as compared to ₹165.69Cr in 2024-03-31.

Net Profit (PAT) was ₹187.96Cr in 2025-03-31 compared with ₹119.11Cr in 2024-03-31.

Earnings per share (EPS) were ₹23.35 in 2025-03-31, compared with ₹14.80 in 2024-03-31.